These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 19789368)

  • 21. A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers.
    Nosho K; Kure S; Irahara N; Shima K; Baba Y; Spiegelman D; Meyerhardt JA; Giovannucci EL; Fuchs CS; Ogino S
    Gastroenterology; 2009 Nov; 137(5):1609-20.e1-3. PubMed ID: 19686742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels.
    Lee S; Cho NY; Yoo EJ; Kim JH; Kang GH
    Arch Pathol Lab Med; 2008 Oct; 132(10):1657-65. PubMed ID: 18834226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum.
    Yamauchi M; Morikawa T; Kuchiba A; Imamura Y; Qian ZR; Nishihara R; Liao X; Waldron L; Hoshida Y; Huttenhower C; Chan AT; Giovannucci E; Fuchs C; Ogino S
    Gut; 2012 Jun; 61(6):847-54. PubMed ID: 22427238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survival.
    Rosty C; Young JP; Walsh MD; Clendenning M; Sanderson K; Walters RJ; Parry S; Jenkins MA; Win AK; Southey MC; Hopper JL; Giles GG; Williamson EJ; English DR; Buchanan DD
    PLoS One; 2013; 8(6):e65479. PubMed ID: 23785428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular alterations of Ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia.
    Yip WK; Choo CW; Leong VC; Leong PP; Jabar MF; Seow HF
    APMIS; 2013 Oct; 121(10):954-66. PubMed ID: 23992303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between molecular subtypes of colorectal cancer and patient survival.
    Phipps AI; Limburg PJ; Baron JA; Burnett-Hartman AN; Weisenberger DJ; Laird PW; Sinicrope FA; Rosty C; Buchanan DD; Potter JD; Newcomb PA
    Gastroenterology; 2015 Jan; 148(1):77-87.e2. PubMed ID: 25280443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions.
    Naito T; Nosho K; Ito M; Igarashi H; Mitsuhashi K; Yoshii S; Aoki H; Nomura M; Sukawa Y; Yamamoto E; Adachi Y; Takahashi H; Hosokawa M; Fujita M; Takenouchi T; Maruyama R; Suzuki H; Baba Y; Imai K; Yamamoto H; Ogino S; Shinomura Y
    World J Gastroenterol; 2014 Aug; 20(29):10050-61. PubMed ID: 25110432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype.
    Nosho K; Kawasaki T; Chan AT; Ohnishi M; Suemoto Y; Kirkner GJ; Fuchs CS; Ogino S
    Histopathology; 2008 Nov; 53(5):588-98. PubMed ID: 18983468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations.
    Ogino S; Kawasaki T; Kirkner GJ; Loda M; Fuchs CS
    J Mol Diagn; 2006 Nov; 8(5):582-8. PubMed ID: 17065427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.
    Ogino S; Nosho K; Kirkner GJ; Kawasaki T; Meyerhardt JA; Loda M; Giovannucci EL; Fuchs CS
    Gut; 2009 Jan; 58(1):90-6. PubMed ID: 18832519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor TP53 expression status, body mass index and prognosis in colorectal cancer.
    Morikawa T; Kuchiba A; Liao X; Imamura Y; Yamauchi M; Qian ZR; Nishihara R; Sato K; Meyerhardt JA; Fuchs CS; Ogino S
    Int J Cancer; 2012 Sep; 131(5):1169-78. PubMed ID: 22038927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP.
    Ogino S; Kawasaki T; Kirkner GJ; Yamaji T; Loda M; Fuchs CS
    Mod Pathol; 2007 Jan; 20(1):15-22. PubMed ID: 17086168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct molecular features of different macroscopic subtypes of colorectal neoplasms.
    Konda K; Konishi K; Yamochi T; Ito YM; Nozawa H; Tojo M; Shinmura K; Kogo M; Katagiri A; Kubota Y; Muramoto T; Yano Y; Kobayashi Y; Kihara T; Tagawa T; Makino R; Takimoto M; Imawari M; Yoshida H
    PLoS One; 2014; 9(8):e103822. PubMed ID: 25093594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.
    Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Kirkner GJ; Dehari R; Meyerhardt JA; Fuchs CS; Ogino S
    Neoplasia; 2007 Jul; 9(7):569-77. PubMed ID: 17710160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review.
    Shima K; Nosho K; Baba Y; Cantor M; Meyerhardt JA; Giovannucci EL; Fuchs CS; Ogino S
    Int J Cancer; 2011 Mar; 128(5):1080-94. PubMed ID: 20473920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy ± cetuximab.
    Smith CG; Fisher D; Claes B; Maughan TS; Idziaszczyk S; Peuteman G; Harris R; James MD; Meade A; Jasani B; Adams RA; Kenny S; Kaplan R; Lambrechts D; Cheadle JP
    Clin Cancer Res; 2013 Aug; 19(15):4104-13. PubMed ID: 23741067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies.
    Ogino S; Cantor M; Kawasaki T; Brahmandam M; Kirkner GJ; Weisenberger DJ; Campan M; Laird PW; Loda M; Fuchs CS
    Gut; 2006 Jul; 55(7):1000-6. PubMed ID: 16407376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers.
    Ogino S; Nosho K; Irahara N; Shima K; Baba Y; Kirkner GJ; Meyerhardt JA; Fuchs CS
    J Clin Oncol; 2009 Sep; 27(27):4591-8. PubMed ID: 19704056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
    Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
    Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis.
    Ogino S; Brahmandam M; Kawasaki T; Kirkner GJ; Loda M; Fuchs CS
    Mod Pathol; 2006 Aug; 19(8):1083-90. PubMed ID: 16699497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.